INS and neurodegenerative disease: Many studies have reported that insulin administered through the nasal cavity can be directly absorbed by the nasal mucosa without passing through the peripheral blood circulation and can enter the brain through the blood–brain barrier to treat neurodegenerative diseases such as AD and cognitive impairment [23,24,25].